Harrow, Inc. (HROW)
36.89
-0.38
(-1.02%)
USD |
NASDAQ |
Aug 31, 16:00
36.89
0.00 (0.00%)
After-Hours: 16:42
Harrow Free Cash Flow : -13.08M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -13.08M |
| March 31, 2026 | 14.11M |
| December 31, 2025 | 42.76M |
| September 30, 2025 | -20.62M |
| June 30, 2025 | -34.62M |
| March 31, 2025 | -36.68M |
| December 31, 2024 | -60.88M |
| September 30, 2024 | 2.956M |
| June 30, 2024 | -20.74M |
| March 31, 2024 | -14.27M |
| December 31, 2023 | -148.71M |
| September 30, 2023 | -166.95M |
| June 30, 2023 | -147.09M |
| March 31, 2023 | -145.81M |
| December 31, 2022 | -6.068M |
| September 30, 2022 | -12.01M |
| June 30, 2022 | -12.95M |
| March 31, 2022 | -13.26M |
| December 31, 2021 | -10.84M |
| September 30, 2021 | 4.179M |
| June 30, 2021 | 8.983M |
| March 31, 2021 | 1.713M |
| December 31, 2020 | -2.094M |
| September 30, 2020 | -0.742M |
| June 30, 2020 | -3.281M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.094M |
| December 31, 2019 | -0.887M |
| September 30, 2019 | -2.458M |
| June 30, 2019 | -2.629M |
| March 31, 2019 | -2.087M |
| December 31, 2018 | -1.516M |
| September 30, 2018 | -1.174M |
| June 30, 2018 | -3.381M |
| March 31, 2018 | -6.914M |
| December 31, 2017 | -9.877M |
| September 30, 2017 | -11.98M |
| June 30, 2017 | -14.21M |
| March 31, 2017 | -17.83M |
| December 31, 2016 | -18.35M |
| September 30, 2016 | -19.87M |
| June 30, 2016 | -18.01M |
| March 31, 2016 | -15.14M |
| December 31, 2015 | -12.72M |
| September 30, 2015 | -10.68M |
| June 30, 2015 | -9.661M |
| March 31, 2015 | -7.846M |
| December 31, 2014 | -7.229M |
| September 30, 2014 | -6.344M |
| June 30, 2014 | -5.615M |
| March 31, 2014 | -5.086M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Viatris, Inc. | 1.806B |
| Zevra Therapeutics, Inc. | 32.62M |
| Indivior Pharmaceuticals, Inc. | -119.51M |
| Liquidia Corp. | 150.69M |
| 60 Degrees Pharmaceuticals, Inc. | -9.063M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.755M |
| Cash from Investing (Quarterly) | -0.534M |
| Cash from Financing (Quarterly) | -0.466M |
| Free Cash Flow Per Share (Quarterly) | -0.7574 |
| Free Cash Flow to Equity (Quarterly) | -28.36M |
| Free Cash Flow to Firm (Quarterly) | -22.03M |
| Free Cash Flow Yield | -0.94% |